Observational studyMedicine2020

Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma.

Xinjian Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.